StonvexLoading…
StonvexStonvexStonvexCore line items from ACNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $74.94M | $80.76M | $193.18M | $46.75M |
Operating Income | $-7.03M | $-10.80M | $-37.43M | Not available |
Net Income | $867.00K | $-13.60M | $-26.63M | $-17.93M |
EPS (Diluted) | $0.09 | $-1.35 | $-2.63 | $-1.77 |
Total Assets | $111.94M | $147.25M | $163.29M | Not available |
Total Liabilities | $24.95M | $53.70M | $55.88M | Not available |
Cash & Equivalents | $57.61M | $16.10M | $1.85M | Not available |
Free Cash Flow OCF − CapEx | $-2.06M | $13.56M | $20.19M | Not available |
Shares Outstanding | 9.40M | 10.07M | 10.07M | 10.13M |